Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where’s that MYDX 10-Q? Over a month delinquent now.
AeroDX, AquaDX and OrganaDX....all "coming soon" since 2015.
How are these perpetually “coming soon” products from MYDX benefitting shareholders?
I don’t see MYDX doing it either.
AeroDX, AquaDX and OrganaDX....all "coming soon" since 2015.
2.1M MYDX volume with 30 minutes to go in trading day, and they're all sells.
Nobody is "scooping up" the "cheapies?"
MYDX volume today so far is 1.6M, all sells. Somebody needed $640 from the MYDX ATM.
In light of Daniel Yazbeck's lawsuit against Jessica Peatross (and her counter-claim), it boggles the mind why people aren't asking why the hell Yazbeck was working on Peatross' company when he has missed so many product deadlines for MYDX.
I mean, the dude was CEO of MYDX at a time when everybody was asking where the hell are the products and services the company said would be coming out. All the while he's busy working on other companies?!
Blank web pages, disguising a dismissed lawsuit as being active, products “coming soon” since 2015 and financial reporting delinquency.
That’s MYDX right now.
Can’t wait for the judge to hear what Jessica Peatross has against MYDX in her case against the company.
In case this is a serious question.....
Because the Securities and Exchange Act and Rule 144 require companies be current on their reports for at least 90 days in order to do such sales or transactions.
Further, companies don’t just call and offer money to buy another without digging deep. They sign NDAs and look at each others books... very closely. And the books would probably show some really dirty laundry not in the Ks or Qs (such as the default judgments and cases in active litigation).
And they sure as hell are going to want to know why the company sued Dewald and Sanzeri for $29M and came out with only a $5K settlement. Additionally, how much was spent to litigate that case and whether the company was required to reimburse Jerome Dewald for his legal expenses, and for how much. And how and why the company was forced to settle the $29M case for $5K to a defendant that, according to the court website, never had legal representation.
Further, companies are going to want to know where every single penny is spent, why and how. Same goes for every single share of the 4.64B+ OS right now.
Companies are going to ask why AeroDX, AquaDX OrganaDX have been talked about in interviews done by Yazbeck, in pump pieces, prospectus documents and in the financials dating back to 2015. Companies are going to want to know where things are with those and why after four years, they’re still “coming soon.”
Companies are going to want to know why MYDX spent at least $1M to market a product in China in 2017 that here in late 2019 still hasn’t been delivered to American customers.
Companies are going to want to know the details and see the paperwork for the Bright Light Marketing deals, the depth of the relationship with Harry Tajyar (someone who has been on the SEC’s radar for awhile now, and I believe has active complaint against him), and other people involved in 2016 and 2017 business dealings.
Companies are going to ask about the Phoenix debt and court cases in 2016 in Florida, they’re going to ask about the Section 3(a)(10) exemptions MYDX appears to believe they and exempt from in 2016 and 2017 and the details behind those people paid for “crisis communications.”
Companies are going to want to know why the vape pen has been “coming soon” since April 2017 and its progress. They’re going to ask much harder, pointed and detailed questions than read here.
Companies are going to want to know why MYDX said it would conduct Israeli Clinical Trials, produce results in Q3 2018, and why there are no results one year later.
Companies are going to want to know why the former MYDX Chief Medical Officer resigned after seven months. They’re going to want to know why she filed a counter-claim against the company. That’s active litigation, companies are not going to overlook that, they’re going to want to know if there’s truth and Yazbeck’s side of the story his side of the story when it comes to the serious accusations of him misrepresenting himself and spending funds outside of intended purposes of Jessica Peatross’ personal business.
Companies are going to want to know why MYDX paid so much to the Mr. Cannabis Group and for the first full quarter of their tenure only brought in $1,539 of Q1 2019 revenue. They’re going to want to know why there were total operating expenses of $495K to show for $1,539 in revenue.
They’re also going to want to know why over $145K in cash and shares was given to Erai Beckmann to consult, advise and promote a product (the pen) in 2018 that is still not available.
AND, they’re going to want to know why the Q1 2019 10-Q was filed late and why the company has yet to file its Q2 2019 financials.
Lastly, a company is going to want to know from Yazbeck what the value is in a company that has $12M in debt, a deficit of $40M and is on track for $6,156 of annual revenue.
So if Yazbeck can produce all that information, then why doesn’t he simply file the 10-Q? He has the information and denies Shareholders their right to know.
To emphasize the opening point, the company is delinquent in its financials, the most basic of requirements in order to be acquired.
That’s why.
It’s doubtful the lack of a current MYDX 10-Q is going to impair Peatross’ ability to pursue Yazbeck for the damages she alleges happened to her company.
Peatross named both Yazbeck and MYDX as defendants, don’t think Yazbeck can escape this suit by not naming himself MYDX CEO again.
The mystery is with the restricted shares.
There are still 2B restricted shares (value $1M). According to Rule 144, Yazbeck needed one year of on-time reporting in order to convert them to unrestricted.
The 10-K was filed April 25, 10 days late....even with the NT filed. Doesn’t that make MYDX non-compliant and resets the clock to another year for Rule 144 and ability to convert those shares?
Hard to believe Yazbeck would leave that kind of cash on the table.
Last one was only 6 weeks late. LOL
But that was when the SCAMtity had a CEO.
Who knows...might be never, which would mean SCAMydx cannot file SOS annual registration, as that requires clear and caught up tax reporting.
I’m sure Jessica Peatross’ counsel has read the MYDX financials. Peatross paying the jury fees shows she’s ready to ask Yazbeck about the MYDX financials.
Best of all.....under oath.
$1,539 in quarterly revenue is not normal.
Spending nearly a half a million in one quarter for G&A is not normal.
Being sued by vendors is not normal.
Being sued by your former Chief Medical Officer after seven months of tenure is not normal.
Having products “coming soon” since 2015 is not normal.
Withholding financials from shareholders is not normal.
Giving someone $1M to promote and market a product in China when it hasn’t even been sold in the U.S. is not normal.
An explosion of dilution to 4.65B shares with one product released is not normal.
Who is complying? By how? What’s the case number?
From 2016.....lol, pretty much sums up MYDX right there.
Only that the company has been saying “coming soon” since 2015.
Great, let’s see how that works out for the company.
Because there is a difference between when a MATTER is not dismissed and a CASE being dismissed.
AGAIN, if this is still going on, PLEASE show the court case number.
Great.....if the case is not dismissed, then what is the case number?
Yazbeck filed the motion with the court to dismiss, and it was granted.
Make it make sense!
Court still says the MYDX case is dismissed.
How is a settlement “dismissed?” Is Yazbeck going to refund Sanzeri the $5K he paid?
Oh, and the fraud “against” MYDX? Back in 2016, MYDX paid at least $1M to market and sell a product in China that to this day hasn’t made is to a single customer in the United States.
“Against” isn’t the right descriptive word.
MYDX OS:
April 2017 = 1.45B
Today = 4.65B
Easier to get to 100M when the OS explodes and the SP nosedives.
The past four weeks have been big on financials in the MJ sector. The big news being a couple of days ago where a company recorded record QoQ earnings, but missed its own revenue forecast. Still, that company, and others are talking about tens and hundreds of millions of dollars in revenue.
Then there's MYDX, recording $1,539 in Q1 2019 revenue on nearly a half million in expenses (in one quarter alone). Now the company is withholding its Q2 2019 financials.
The missing financials is not just an oversight, it should be very problematic in the minds of MYDX shareholders. No "acquisition" can happen with an SEC-delinquent company.
Been around long enough to remember "MYDX 2018!!!" At least they had revenue and were filing financials back then.
Would like to note that the Form 4 was SIGNED ON JULY 16 2018 but the earliest transaction is May 16 2018... WOW.. what about that.....
Oh it's not just a billion, it's more than that.
Yazbeck filed a Form 4 last year for 1.75B alone.
Comb through the MYDX fins and notice all the loans, shares and deal both for Yazbeck personally and for Yazbeck's privately owned YCIG (Yazbeck Consulting Investment Group).
Company can't be sold any time soon anyway. MYDX 10-Q is over a month overdue, and Rule 144 requires minimum 90 days of on-time financial reporting (company was weeks late with Q1 2019 10-Q).
Those vendors MYDX haven't paid have are rather Salty.
Don't forget the Cedar Business Services case against MYDX appears to be resurrected, under "Post Judgment" status. Meaning there's a pretty good chance MYDX did not pay the judgment and Cedar is taking MYDX back to court.
Is MYDX dead? Alan Brochstein called it essentially dead last year, but is it time to remove the qualifier? Over three hours into the trading day and zero volume.
Or else what?
Wow, that’s very interesting. What’s the case number of that MYDX lawsuit?
Why? MYDX already withdrew its $29,000,000.00 suit and settled for $5K.
Wonder how much MYDX had to reimburse Jerome Dewald in legal fees.
Doesn’t look like they have to reimburse Skip Sanzeri, because he negotiated a settlement 99.98% less original asking price WITHOUT legal representation.....LOL.
WHOOPSIE! Did MYDX forget to pay the judgment to Cedar Business Services?
On October 16, 2018.....
Judgment was entered as follows: Judgment entered for Cedar Business Services LLC and against CDX Inc. A DELAWARE CORPORATION for $ 55053.00, punitive damages: $ 0.00, attorney fees: $ 1991.59, interest: $ 11725.73, prejudgment costs: $ 565.00, other costs: $ 0.00, amount payable to court: $ .00, for a grand total of $ 69335.32
WHOOPSIE! Did MYDX forget to pay the judgment to Cedar Business Services?
On October 16, 2018.....
Judgment was entered as follows: Judgment entered for Cedar Business Services LLC and against CDX Inc. A DELAWARE CORPORATION for $ 55053.00, punitive damages: $ 0.00, attorney fees: $ 1991.59, interest: $ 11725.73, prejudgment costs: $ 565.00, other costs: $ 0.00, amount payable to court: $ .00, for a grand total of $ 69335.32
What about AeroDX, AquaDX and OrganaDX the company says is "coming soon" since 2015?
No proof the customer ever received the products from MYDX either.
There is ABSOLUTELY NO PROOF that the customer never received the items that were ordered in the first place from MYDX. IMO, just another attempt to slander MYDX.
Huh? There's no guilt or innocence in a SMALL CLAIMS court case.
MYDX either refunded the money or they delivered the product the customer paid for.
Slimpen? LOL.
I was told that MYDX was going to have products released with Slimpen many times. On July 18, 2018 (yes, 2018), July 27, 2019 and August 8, 2019. Turns out those were all lies.
Maybe the reason the MYDX matter has not been dismissed yet is because the company is investigating those false and misleading claims and pursuing action for those damages.
MYDX closed at .004 on July 18, 2018....MYDX SP down 90% since then. I too would be Salty if I believed an MYDX product was said to be released, but didn’t.